BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36656393)

  • 1. Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms.
    Manethova M; Gerykova L; Faistova H; Drugda J; Hacova M; Hornychova H; Ryska A; Gabalec F; Soukup J
    Virchows Arch; 2023 Apr; 482(4):679-686. PubMed ID: 36656393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms.
    Soukup J; Manethova M; Stejskal V; Novakova M; Duskova J; Hornychova H; Hacova M; Staniczkova-Zambo I; Zelinka T; Kosak M; Cesak T; Netuka D; Ryska A; Gabalec F
    Endocr Pathol; 2024 Mar; 35(1):14-24. PubMed ID: 38416360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
    Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
    Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors.
    Soukup J; Manethova M; Stejskal V; Hornychova H; Cesak T; Netuka D; Ryska A; Gabalec F
    Endocr Pathol; 2023 Sep; 34(3):333-341. PubMed ID: 37552455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.
    Miyauchi M; Akashi T; Furukawa A; Uchida K; Tamura T; Ando N; Kirimura S; Shintaku H; Yamamoto K; Ito T; Miura K; Kayamori K; Ariizumi Y; Asakage T; Kudo A; Tanabe M; Fujii Y; Ishibashi H; Okubo K; Murakami M; Yamada T; Takemoto A; Bae Y; Eishi Y; Ohashi K
    Endocr Pathol; 2022 Dec; 33(4):506-518. PubMed ID: 36029394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours.
    Hung YP; Lee JP; Bellizzi AM; Hornick JL
    Histopathology; 2017 Nov; 71(5):786-794. PubMed ID: 28640941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of gata3 and phox2b expression in tumors of the autonomic nervous system.
    Nonaka D; Wang BY; Edmondson D; Beckett E; Sun CC
    Am J Surg Pathol; 2013 Aug; 37(8):1236-41. PubMed ID: 23715162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
    Warren M; Matsuno R; Tran H; Shimada H
    Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases.
    Soukup J; Manethova M; Faistova H; Krbal L; Vitovcova B; Hornychova H; Drugda J; Cesak T; Netuka D; Gabalec F; Ryska A
    Histopathology; 2022 Dec; 81(6):799-807. PubMed ID: 36089904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.
    Soukup J; Manethova M; Kohout A; Soukup T; Dvorakova R; Drugda J; Vitovcova B; Gabalec F; Kaiser M; Kanta M; Kasparova P; Kozak J; Michnova L; Netuka D; Reguli S; Rychly B; Trnkova M; Vachata P; Wozniakova M; Cesak T
    Virchows Arch; 2023 Feb; 482(2):325-338. PubMed ID: 36348031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.
    Hoskoppal D; Epstein JI; Gown AM; Arnold Egloff SA; Gordetsky JB; Shi CJ; Giannico GA
    Histopathology; 2020 Mar; 76(4):550-559. PubMed ID: 31595536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHOX2B as a Reliable Marker for Neuroblastoma in Tissue and Cytology Specimens.
    Ma Y; Feng J; Zhao J; Ding D; Tian F; Chen L; Zheng J; Xiao X
    J Neuropathol Exp Neurol; 2021 Dec; 80(12):1108-1116. PubMed ID: 34965292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HuC/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors.
    Takemoto J; Kuda M; Kohashi K; Yamada Y; Koga Y; Kinoshita I; Souzaki R; Taguchi T; Oda Y
    Hum Pathol; 2019 Mar; 85():162-167. PubMed ID: 30468801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma.
    Kimura N; Shiga K; Kaneko K; Sugisawa C; Katabami T; Naruse M
    Endocr Pathol; 2020 Jun; 31(2):95-100. PubMed ID: 32303954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
    Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
    Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cadherin 17 in well-differentiated neuroendocrine tumours.
    Snow AN; Mangray S; Lu S; Clubwala R; Li J; Resnick MB; Yakirevich E
    Histopathology; 2015 Jun; 66(7):1010-21. PubMed ID: 25388236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors.
    Mete O; Kefeli M; Çalışkan S; Asa SL
    Mod Pathol; 2019 Apr; 32(4):484-489. PubMed ID: 30390035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
    Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
    APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.